Breaking News, Promotions & Moves

Romaco Appoints New Group CFO and Managing Director

Ann-Xiaoyan Li offers extensive management experience as CFO at various mid-market companies in the automotive and commercial vehicle sectors.

Romaco Holding GmbH has appointed Ann-Xiaoyan Li as Group Chief Financial Officer (CFO) and Managing Director of the Romaco Group, succeeding Markus Kimpel, who has left the company. Romaco is an international manufacturer of processing and packaging technologies for the pharmaceutical, food, and chemical industries.
 
Li will be responsible for Finance & Controlling, HR Services and IT Management at Romaco Holding GmbH as well as Finance & Controlling at the Romaco Group’s six production sites and ten international Sales & Service Centers (SSC).
 
“I’m delighted we’ve been able to get Ann-Xiaoyan Li on board the management of the Romaco Group and as Group CFO,” said Jens Torkel, Managing Director Romaco Group. “She impressed me with her clear and pragmatic style of leadership, which is just what we need to gain optimal benefit from the synergistic effects within the group and boost our internal efficiency. Her presence on the management team will allow us to continue standardizing processes throughout our decentralized corporate structure as we drive the expansion of our worldwide service network.”
 
Li has extensive management experience as CFO at various mid-market companies in the automotive and commercial vehicle sectors. She initially completed a Bachelor’s degree in International Finance at Northwest University in Xi’an (China) before going on to study for a Bachelor and Master of Business Administration at Bielefeld University (Germany).
 
“I’m looking forward with great excitement and fire in my belly to my new tasks at this old-established and yet highly dynamic, globally operating group of companies,” emphasized Li. “I see myself as a reliable partner to the Business Units, Sales & Service Centers and specialist departments that report to me, all of which are united by a common goal: to generate growth and tap into new markets with a proactive approach and strategic solutions.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters